Interventions including inverse agonists, antagonists and natural products have exhibited significant clinical efficacy in ameliorating the pathological characteristics of conditions such as psoriasis, underscoring IL-17 as a vital therapeutic target [19,20,21]. Here, IL17A is linked to psoriasis.